Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Clinical Medicine|July 12, 2025
Efficacy and Safety of Low-Dose Rivaroxaban in High-Ischemic-Risk Patients with Chronic Coronary Syndrome: Rationale and Design of the DUTCH CCS RegistryAbi Selvarajah, Dirk J van der Heijden, Wouter S Remkes, et al.
International Journal of Cardiology. Heart & Vasculature|February 20, 2026
The impact of pullback measurement on treatment decision in significant coronary artery disease: Insights from a retrospective multicentric studyRoberto Bova, Matteo Betti, Samuel Heuts, et al.
Diabetes/Metabolism Research and Reviews|April 8, 2022
Short-term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new-generation drug-eluting stentNousjka P A Vranken, Saman Rasoul, Jasper J P Luijkx, et al.
Circulation. Cardiovascular Quality and Outcomes|June 30, 2011
Upstream use of small-molecule glycoprotein iib/iiia inhibitors in patients with non-ST-segment elevation acute coronary syndromes: a systematic overview of randomized clinical trialsPierluigi Tricoci, L Kristin Newby, Vic Hasselblad, et al.
The American Journal of Cardiology|April 3, 2018
Comparison of Outcomes and Intervention Among Patients With Non-ST-Segment Elevation Acute Myocardial Infarction of Those With a Left Circumflex Versus Those With a Non-Left Circumflex-Related Coronary Artery (From the ELISA-3 Trial)Erik A Badings, Renicus S Hermanides, Salem H K The, et al.
JAMA|August 31, 2025
Fractional Flow Reserve-Guided Complete vs Culprit-Only Revascularization in Non-ST-Elevation Myocardial Infarction and Multivessel Disease: The SLIM Randomized Clinical TrialTobias F S Pustjens, Leo Veenstra, Cyril Camaro, et al.
BMJ Open|July 8, 2021
Identification of anatomic risk factors for acute coronary events by optical coherence tomography in patients with myocardial infarction and residual nonflow limiting lesions: rationale and design of the PECTUS-obs studyJan-Quinten Mol, Anouar Belkacemi, Rick Hja Volleberg, et al.
European Heart Journal. Cardiovascular Imaging|November 8, 2024
High-risk plaques in non-culprit lesions and clinical outcome after NSTEMI vs. STEMIRick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|July 31, 2020
Impact of opioids on P2Y12 receptor inhibition in patients with ST-elevation myocardial infarction who are pre-treated with crushed ticagrelor: Opioids aNd crushed Ticagrelor In Myocardial infarction Evaluation (ON-TIME 3) trialAnne H Tavenier, Renicus S Hermanides, Jan Paul Ottervanger, et al.
Atherosclerosis|September 6, 2024
Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarctionRick H J A Volleberg, Jan-Quinten Mol, Anouar Belkacemi, et al.
Pageof 6